During the past decade, Denver Arthritis Clinic conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 20 clinical trials were completed, i.e. on average, 95.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 11 clinical trials were completed. i.e. 220% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Denver Arthritis Clinic" #1 sponsor was "Eli Lilly and Company" with 6 trials, followed by "Hoffmann-La Roche" with 4 trials sponsored, "Bristol-Myers Squibb" with 3 trials sponsored, "R-Pharm International, LLC" with 3 trials sponsored and "Amgen" with 3 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Denver Arthritis Clinic" #1 collaborator was "OCT Clinical Trials" with 3 trials as a collaborator, "Hexal AG" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Galapagos NV" with 1 trials as a collaborator and "IQVIA Pvt. Ltd" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Denver Arthritis Clinic" are "Rheumatoid Arthritis" (16 trials), "Systemic Lupus Erythematosus" (4 trials), "Lupus Erythematosus, Systemic" (3 trials), "Sjogren's Syndrome" (3 trials) and "Arthritis, Psoriatic" (2 trials). Many other conditions were trialed in "Denver Arthritis Clinic" in a lesser frequency.

Most popular intervention types in "Denver Arthritis Clinic" are "Drug" (32 trials), "Biological" (5 trials), "Other" (3 trials), "Genetic" (2 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (15 trials), "Ixekizumab" (2 trials), "MM-093" (2 trials), "acetaminophen" (2 trials) and "methotrexate" (2 trials). Other intervention names were less common.

The vast majority of trials in "Denver Arthritis Clinic" are 36 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Denver Arthritis Clinic". undefined are not yet recruiting, 4 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 29 completed trials in Denver Arthritis Clinic, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Denver Arthritis Clinic, 2 "Phase 1" clinical trials were conducted, 16 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".